Bempedoic acid/Ezetimibe Prescribing at MYRTLE GROUP PRACTICE
Lipid-regulating drugs | Cardiovascular System
Items (12m)
168
Total Quantity
6,776
NHS Cost
£12.7K
vs National Avg
+175.1%
MYRTLE GROUP PRACTICE prescribed 168 items of Bempedoic acid/Ezetimibe over the last 12 months at a cost of £12,748 to the NHS. This is 175.1% above the national average prescribing rate. Bempedoic acid/Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
8
Jun 2026
8
Jun 2026
10
Jun 2026
9
Jun 2026
15
Jun 2026
12
Jun 2026
15
Jun 2026
19
Jun 2026
17
Jun 2026
17
Jun 2026
19
Jun 2026
19
Prescribing Details
| Total Items | 168 |
|---|---|
| Total Quantity | 6,776 |
| Total NHS Cost | £12,748 |
| Presentations | 2 different forms |
| vs National Average | +175.1% |
Bempedoic acid/Ezetimibe Prescribing Comparison
| This practice | 168 items |
|---|---|
| National average per practice | 61 items |
| Difference | +175.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.